Description of Neurocognitive and Psychiatric Disorders Associated With Targeted Therapies Used in the Treatment of Lung Cancers With ALK/ROS1 Fusion and Their Impact on Patients' Quality of Life: Construction of an Experimental Patient-researcher Collaborative Care and Research Pathway
Clinical trial NCT06781905 · RECRUITING
Trial details
- NCT number
- NCT06781905
- Sponsor
- Hospices Civils de Lyon
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-16
- Primary completion
- 2027-05-09
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.